N10 Wealth’s AbbVie ABBV Stock Holding History

N10 Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$283K	Buy	+1,080	New	+$277K	0.08%	55

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

N10 Wealth's ABBV Position: Q3 2026 in Review

N10 Wealth opened a new position in AbbVie (ABBV) in Q3 2026: 1,080 shares worth $283K. The stake represents 0.08% of the portfolio and ranks #55 among its holdings.

1,657 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

N10 Wealth held 1,080 shares of AbbVie worth $283K as of Q3 2026.
AbbVie was a new N10 Wealth position in Q3 2026.
AbbVie made up 0.08% of N10 Wealth's portfolio in Q3 2026, its #55 holding.
1,657 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on N10 Wealth's 13F filing for Q3 2026, filed 14 Oct 2026.